Editor-in-chief
Maria Stella Graziani

Deputy Director
Martina Zaninotto

Associate Editors
Ferruccio Ceriotti
Davide Giavarina
Bruna Lo Sasso
Giampaolo Merlini
Martina Montagnana
Andrea Mosca
Paola Pezzati
Rossella Tomaiuolo
Matteo Vidali

International Advisory Board Khosrow Adeli Canada
Sergio Bernardini Italy
Marcello Ciaccio Italy
Eleftherios Diamandis Canada
Kjell Grankvist Sweden
Hans Jacobs The Netherlands
Eric Kilpatrick UK
Magdalena Krintus Poland
Giuseppe Lippi Italy
☩Howard Morris Australia
Mario Plebani Italy
Sverre Sandberg Norway
Ana-Maria Simundic Croatia
☩Jill Tate Australia
Tommaso Trenti Italy
Cas Weykamp The Netherlands
Maria Willrich USA
Paul Yip Canada


Publisher
Biomedia srl
Via L. Temolo 4, 20126 Milano

Responsible Editor
Giuseppe Agosta

Editorial Secretary
Arianna Lucini Paioni
Biomedia srl
Via L. Temolo 4, 20126 Milano
Tel. 0245498282
email: biochimica.clinica@sibioc.it



Area soci
Non possiedi o non ricordi la password!
Clicca qui

BC: Articoli scritti da C. Carrozza

Valori falsamente elevati di triodotironina libera in una paziente affetta da tiroidite cronica e gozzo multinodulare
Falsely increased free triiodothyronine values in a woman affected by thyroiditis and multinodular goiter
<p>We&nbsp;describe a case of a 63-years old woman affected by Hashimoto&rsquo;s thyroiditis and multinodular goiter. Her laboratory&nbsp;results showed elevated free triiodothyronine (FT3) concentrations (18.5 ng/L), with free thyroxine (FT4) and&nbsp;thyrotropin (TSH) within the physiologic range. On the basis of these results, she started methimazole therapy, with&nbsp;persistence of inappropriately elevated FT3 concentrations. The therapy was thus stopped and blood examination&nbsp;was repeated after one month in our laboratory: concentrations of thyroid tests were within the physiologic range,&nbsp;including FT3 (2.8 ng/L). The difference between this result and that previously obtained raised the suspicion of the&nbsp;presence of an interference in the first result. In fact, in our laboratory a competitive electrochemiluminescence&nbsp;immunoassay with labeled antibody is used, while the first laboratory employed a competitive chemiluminescence&nbsp;immunoassay with labeled analogue, which has a more important risk of interference. After treating sample by&nbsp;polyethylene glycol, FT3 resulted indeed normal also by the immunoassay used by the first laboratory.</p>
Biochimica Clinica ; 38(1) 70-72
Casi clinici - Case report